Suppr超能文献

腹腔镜微波凝固与腹腔镜射频消融治疗效果的对比研究

A comparative study of therapeutic effect between laparoscopic microwave coagulation and laparoscopic radiofrequency ablation.

作者信息

Iida Hiroya, Aihara Tsukasa, Ikuta Shinichi, Yamanaka Naoki

出版信息

Hepatogastroenterology. 2013 Jun;60(124):662-5. doi: 10.5754/hge12801. Epub 2012 Nov 23.

Abstract

BACKGROUND/AIMS: We retrospectively compared the therapeutic effect of microwave coagulation needle (Lap-MCT) and radiofrequency ablation needle (Lap-RFA).

METHODOLOGY

Between January 2001 and May 2012, 71 patients underwent laparoscopic ablation therapy for HCC with no extra hepatic metastasis. These patients were divided into 3 groups, according to the surgical strategies: Lap-MCT (n=40), Lap-MCT+RFA (n=13) and Lap-RFA (n=18). The patient background, tumor characteristics, cumulative survival rate, recurrence-free survival rate, time of operation and duration of hospitalization were compared between the groups.

RESULTS

The maximal tumor size, the number of tumors and the hepatic reserve from each group had no significant difference. Likewise, the time of operation and the duration of hospitalization had no significant difference. However, the number of needle punctures in the Lap-MCT group was significantly larger than that in the Lap-RFA group (p<0.05). Postoperative liver function had no significant difference between the groups. The 5-year cumulative survival rate was 71.5% (Lap-MCT), 66.7% (Lap-MCT+RFA) and 80.0% (Lap-RFA) showing no significant difference. Also, the recurrence-free survival rate and the local recurrence rate had no significant difference.

CONCLUSIONS

In the laparoscopic setting, MCT and RFA are equally effective in terms of short- and long-term results.

摘要

背景/目的:我们回顾性比较了微波凝固针(Lap-MCT)和射频消融针(Lap-RFA)的治疗效果。

方法

2001年1月至2012年5月期间,71例无肝外转移的肝癌患者接受了腹腔镜消融治疗。根据手术策略,这些患者被分为3组:Lap-MCT组(n = 40)、Lap-MCT + RFA组(n = 13)和Lap-RFA组(n = 18)。比较了各组患者的背景、肿瘤特征、累积生存率、无复发生存率、手术时间和住院时间。

结果

每组的最大肿瘤大小、肿瘤数量和肝脏储备无显著差异。同样,手术时间和住院时间也无显著差异。然而,Lap-MCT组的穿刺针数明显多于Lap-RFA组(p < 0.05)。各组术后肝功能无显著差异。5年累积生存率分别为Lap-MCT组71.5%、Lap-MCT + RFA组66.7%和Lap-RFA组80.0%,无显著差异。此外,无复发生存率和局部复发率也无显著差异。

结论

在腹腔镜手术中,MCT和RFA在短期和长期结果方面同样有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验